Friday 6 November 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024.

Revenue: +3.75%
EPS: −14.7%
Free cash flow: +62.4%
Total debt: +33.2%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

50.39 0.76 −1.49%

Follow GSK

Alert me

Market cap: $101.0B
P/E: 16.7×
Fwd P/E: 14.6×
Dividend yield: 3.60%
F-score: 9/9
Altman Z: 2.12
Beneish M: −2.46
Dividend safety: 54/100

Overview

GSK PLC Sponsored ADR (GSK) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, GSK PLC Sponsored ADR (GSK) trades at a P/E ratio of 16.7×. Over the past ten years it has ranged from 3.6× (September 2022) to 1,213× (August 2016); the current reading is higher than 50% of that period. That is below the Drug Manufacturers General industry median of 26.6× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/GSK/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="GSK PLC Sponsored ADR P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/GSK/metrics/pe-ratio">GSK PLC Sponsored ADR (GSK) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	13.2×	(37.47%)
FY2024	21.1×	70.18%
FY2023	12.4×	205.14%
FY2022	4.1×	(77.76%)
FY2021	18.3×	46.70%
FY2020	12.5×	(36.82%)
FY2019	19.7×	0.77%
FY2018	19.6×	(58.08%)
FY2017	46.7×	(42.23%)
FY2016	80.9×	1,226.05%

Period	P/E ratio	Change
Sep 2026	16.0×	(2.09%)
Jun 2026	16.3×	14.51%
Mar 2026	14.3×	7.89%
Dec 2025	13.2×	8.72%
43 more quarters	Free account

Against its own ten years

Low 3.6× High 1,213×

Ten-year median 16.7×

Current reading's percentile 48

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
NVO Novo Nordisk A/S compare	9.9×
BMY Bristol Myers Squibb Company compare	14.0×
GSK GSK PLC Sponsored ADR	16.7×
SNY Sanofi compare	23.2×
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
PFE Pfizer Inc. compare	42.2×
BIIB Biogen Inc. compare	104×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

GSK PLC Sponsored ADR (GSK) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on GSK

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on GSK

Stockrow Weekly